DESCRIPTION: (Adapted From The Applicant's Abstract) Neurotrophins are
known to contribute to critical developmental processes in the nervous
system. Recent studies by the applicant have shown that neurotrophins
are expressed in the developing mammalian olfactory epithelium during
the time that synaptic connections are being made with the developing
forebrain. At this time, cells in the rostral telencephalon express the
appropriate tyrosine kinase trk receptors for these neurotrophins and
the olfactory bulbs begin to form. The spatial and temporal patterns
of expression suggest the hypothesis that developing sensory neurons in
the olfactory epithelium anterogradely transport specific neurotrophin
factors to responsive forebrain neurons and thereby contribute to
development of the olfactory bulb. The goals of the proposed research
are to test aspects of this hypothesis. The first specific aim is to
identify the specific cell types expressing different neurotrophins and
their receptors in the epithelium and bulb. In particular we wish to
determine if neurotrophin mRNAs are expressed by olfactory sensory
neurons and if neurotrophin proteins are localized within olfactory
nerve projections. Cell types will be identified by colocalization of
neurotrophin/receptor mRNA and protein with phenotypic markers specific
for subpopulations of olfactory cells The second aim is to determine if
the olfactory nerve anterogradely transports neurotrophins from the
epithelium to the bulb, and if this has functional consequences.
Studies will determine if colchicine treatment increases neurotrophin
immunoreactivity in sensory neurons while decreasing immunoreactivity
in olfactory axons and terminals. We will also evaluate the
redistribution of radiolabeled neurotrophins applied to the olfactory
epithelium, and measure levels of bulb trk phosphorylation following
such treatment. The third aim is to determine if early neurotrophic
factor deprivation leads to morphological or phenotypic abnormalities
in the bulb. This will be accomplished by evaluating olfactory system
development in mice carrying targeted mutations in neurotrophin genes.
The levels, distribution and cellular localization of neurotrophin and
trk expression, and of phenotypic cell markers, will be examined in the
normal and neurotrophin-deprived olfactory system. Differences in
patterns of cell death in forebrain and bulb neuron morphology will also
be examined. The final aim is to determine if early neurotrophin
deprivation has functional consequences in this system by evaluating
bulb trk phosphorylation and odor-stimulated c-fos expression in
knockout mice and control littermates. Results of these studies will
contribute to our understanding of the molecular signals that regulate
mammalian forebrain development.
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
004147534
UEI
Q266L2NDAVP1
Project Start Date
01-August-1998
Project End Date
31-July-2003
Budget Start Date
01-August-2001
Budget End Date
31-July-2002
Project Funding Information for 2001
Total Funding
$100,804
Direct Costs
$72,003
Indirect Costs
$28,801
Year
Funding IC
FY Total Cost by IC
2001
National Institute on Deafness and Other Communication Disorders
$100,804
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R29DC003547-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R29DC003547-04
Patents
No Patents information available for 7R29DC003547-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R29DC003547-04
Clinical Studies
No Clinical Studies information available for 7R29DC003547-04
News and More
Related News Releases
No news release information available for 7R29DC003547-04
History
No Historical information available for 7R29DC003547-04
Similar Projects
No Similar Projects information available for 7R29DC003547-04